fbpx



Weight Loss Medication

When to Stop Weight Loss Medication *

Posted: Jun 29 in Weight Loss Medication by

Perhaps the most common question I get from both referring doctors and patients is, “When should weight loss medication be stopped?” In the good old days, it was thought that if a person could lose weight and keep it off for a time, the body would accept this lower weight as a new setpoint, and […]

Tagged: | Comments: one response

New Weight Loss Medication Wegovy™ Approved by the FDA *

Posted: Jun 04 in Weight Loss Medication by

Today the FDA approved semaglutide 2.4 mg weekly injection for chronic weight management. The brand name will be Wegovy™.* The molecule semaglutide has been used for the treatment of type II diabetes for the past 5 years at doses of up to 1 mg. Novo Nordisk is also seeking an approval for a 2 mg […]

Tagged: , | Comments: 18 responses

Semaglutide 2.4 mg – New Weight Loss Medication Preview… *

Posted: Feb 14 in Weight Loss Medication by

Just published in the New England Journal, as part of a weight loss program, the addition of semaglutide helped people with obesity lose an average of 15% of their body weight during 68 weeks of treatment. This equated to an average of 34 pounds of weight loss during the trial. Heart Safety of Semaglutide As […]

Tagged: , | Comments: None

Plenity – a New Option for Weight Loss *

Posted: Jan 30 in Medical Weight Loss News, Weight loss, Weight Loss Medication by

Plenity is an aid for weight management in adults with a body mass index (BMI) of 25 to 40, when combined with a healthy eating and physical activity plan. Dr. Lazarus and Heather Thomas, PA-C are excited to announce that they have been accepted to the early prescriber program for Plenity. Although Plenity is planning […]

Tagged: | Comments: None

Saxenda – Weight Loss, or Chronic Weight Management? *

Posted: Jan 19 in Weight Loss Medication by

Saxenda is the newest medication approved by the FDA for chronic weight management. Unlike the other medications which are taken as pills or capsules, Saxenda is a once daily self-administered injection. Originally marketed as Victoza for the treatment of type 2 diabetes back in 2010, Saxenda is the same molecule (liraglutide), but underwent rigorous clinical […]

Tagged: , | Comments: 4 responses